These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7774812)

  • 1. Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice.
    Cui W; Fowlis DJ; Cousins FM; Duffie E; Bryson S; Balmain A; Akhurst RJ
    Genes Dev; 1995 Apr; 9(8):945-55. PubMed ID: 7774812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition.
    Wang XJ; Greenhalgh DA; Bickenbach JR; Jiang A; Bundman DS; Krieg T; Derynck R; Roop DR
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2386-91. PubMed ID: 9122204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered epidermal cell growth control in vivo by inducible expression of transforming growth factor beta 1 in the skin of transgenic mice.
    Fowlis DJ; Cui W; Johnson SA; Balmain A; Akhurst RJ
    Cell Growth Differ; 1996 May; 7(5):679-87. PubMed ID: 8732677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis.
    Ito Y; Sarkar P; Mi Q; Wu N; Bringas P; Liu Y; Reddy S; Maxson R; Deng C; Chai Y
    Dev Biol; 2001 Aug; 236(1):181-94. PubMed ID: 11456453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
    Rodriguez C; Chen F; Weinberg RA; Lodish HF
    J Biol Chem; 1995 Jul; 270(27):15919-22. PubMed ID: 7608141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
    J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin.
    Vorstenbosch J; Nguyen CM; Zhou S; Seo YJ; Siblini A; Finnson KW; Bizet AA; Tran SD; Philip A
    J Invest Dermatol; 2017 Mar; 137(3):641-649. PubMed ID: 27866969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
    Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
    Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
    Wikström P; Bergh A; Damber JE
    Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
    Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
    Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.
    Gold LI; Sung JJ; Siebert JW; Longaker MT
    Am J Pathol; 1997 Jan; 150(1):209-22. PubMed ID: 9006337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis.
    Leivo T; Leivo I; Kariniemi AL; Keski-Oja J; Virtanen I
    Br J Dermatol; 1998 Jan; 138(1):57-62. PubMed ID: 9536223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
    Nørgaard P; Spang-Thomsen M; Poulsen HS
    Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids stimulate selectively transforming growth factor (TGF)-beta receptor type III expression in transdifferentiating hepatic stellate cells.
    Wickert L; Abiaka M; Bolkenius U; Gressner AM
    J Hepatol; 2004 Jan; 40(1):69-76. PubMed ID: 14672616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
    Amendt C; Schirmacher P; Weber H; Blessing M
    Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
    Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
    J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.